-
IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. et al DC
- 2:15-cv-06934
- D.N.J.
- Judge: Stanley R. Chesler +1
- Filed: 09/17/2015
- Closed: 06/25/2018
- Latest Docket Entry: 01/15/2019
- PACER
- Docket updated daily
1
Plaintiff
2
Defendants
1
Accused
Product
6
Patents-in-Suit
1,013
Days in
Litigation
-
IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. et al DC
- 2:15-cv-06934
- D.N.J.
- Judge: Stanley R. Chesler +1
- Filed: 09/17/2015
- Closed: 06/25/2018
- Latest Docket Entry: 01/15/2019
- PACER
- Docket updated daily
Cause of Action
Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Actavis Laboratories FL Incorporated
- 2 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
23.75 mg/95 mg36.25 mg/145 mg48.75 mg/195 mg61.25 mg/245 mg dosages | US 8,557,283 B2 |
1, 2, 3, 5
|
No infringement
Entry 180
|
23.75 mg/95 mg36.25 mg/145 mg48.75 mg/195 mg61.25 mg/245 mg dosages | US 9,089,608 B2 |
5, 8, 10, 13, 17, 18, 19, 21
|
No infringement
Entry 180
|
Actavis Pharma Incorporated
- 2 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
23.75 mg/95 mg36.25 mg/145 mg48.75 mg/195 mg61.25 mg/245 mg dosages | US 8,557,283 B2 |
1, 2, 3, 5
|
No infringement
Entry 180
|
23.75 mg/95 mg36.25 mg/145 mg48.75 mg/195 mg61.25 mg/245 mg dosages | US 9,089,608 B2 |
5, 8, 10, 13, 17, 18, 19, 21
|
No infringement
Entry 180
|